MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
MissionIRNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Announces Q3 2020 Results
Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, on Thursday announced financial results for the third quarter ended September 30, 2020. According to the update, Foresight ended the quarter with…
-
MissionIRNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Q2 Results, Provides Update on CNS Pipeline and Business Progress
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, today reported its financial results for the fiscal 2021 second quarter ended September 30, 2020.…
-
MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Poised at Convergence of AI, Cancer Care
Predictive Oncology (NASDAQ: POAI), a knowledge-driven precision medicine company, focuses on applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery. The company is set to play a key role as the integration…
-
VistaGen Therapeutics Inc. (NASDAQ: VTGN) CEO Discusses ‘Game-Changing’ Potential of Drug Pipeline Lineup in Stock2Me Podcast
VTGN is committed to developing and commercializing differentiated new generation medications that go beyond the current standard of care for anxiety, depression and other CNS disorders. VTGN currently has three drugs in its pipeline, PH94B…
-
MissionIRNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Reports Positive Preclinical Data on PH94B’s Mechanism of Action
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, today announced new in vitro electrophysiology data. According to the update, the data demonstrate that…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Financial Results for Third Quarter
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has released its financial results for Q3 2020. In addition, the company reported on important third-quarter highlights and provided an update on key objectives.…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Hosting Webcast for Discussion of Phase 2 Clinical Trial Design
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, has scheduled a webcast today during which it will be discussing…
-
MissionIRNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Announces Its Addition to MSCI China Small Cap Index
iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, has announced that its stock will be added to the MSCI China Small Cap Index. That addition is scheduled to take…
-
Sustainable Green Team Ltd. (SGTM) Completes Audit, Moves One Step Closer to Uplisting
SGTM completes two-year audit in preparation for upcoming SEC Form-10 filing Company targets fully reporting status, NASDAQ tier listing Subsidiary to supply mulch products, services to Midwest, Western New York 7-Eleven stores Sustainable Green Team…
-
Predictive Oncology (NASDAQ: POAI) CEO Joins NNW Podcast to Discuss Company’s Prospects; Provides Update on POAI Subsidiaries
Predictive Oncology CEO Carl Schwartz featured on NNW’s podcast to discuss the company’s prospects Schwartz elaborated on company’s various divisions, affirming that POAI had begun to see revenue trends stabilize, cash burn rates decline TumorGenesis…
-
MissionIRNewsBreaks – Knightscope Inc. Enters $39B Self-Storage Industry
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous robots focused on enhancing U.S. security operations, has a signed agreement to utilize its autonomous security robots at a storage facility in Southern California.…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Awarded First US Patent for Revolutionary UST(TM) Platform
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, today announced the award of the first U.S. patent…
-
MissionIRNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Announces Plan to Acquire Leading Automation Solution Provider
iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, has entered into an agreement to acquire the entire issued share capital of CMRS Group Holding Limited (“CMRS”). CMRS, a leading…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Participate in Life Sciences Summit Panel
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its senior vice president of intellectual property and licensing, Thomas Gallagher, will participate…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Discuss Q3 Financials During Nov. 16 Call
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies, has announced an upcoming conference call. During the call, SRAX management will discuss the company’s Q3 financial report. The…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) Goes Public on Canada’s Next-Gen Stock Exchange
Cybin (NEO: CYBN), a leading Toronto-based biotech and life sciences company focused on psychedelic pharmaceutical therapies, today made its debut on the global public markets and is now trading on the NEO Exchange under the…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Plans to Present at Virtual Fall Investor Summit
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that management will present at the Virtual Fall Investor Summit, hosted by Investor Summit Group and taking place November 16-18,…
-
Alkaline88 Eyes Professional Sports (NASDAQ: WTER) (CSE: WTER)
PGA, MLB changes CBD policies; other leagues evaluating policy changes regarding marijuana, CBD use Global market for CBD oil projected to grow from $967.2 million in 2020 to $5.3 billion by 2025 WTER offers an…
-
MissionIRNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Completion of Strategic Merger
180 Life Sciences (NASDAQ: ATNF, ATNFW), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced the successful closing of its transaction…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Expands A88CBD(TM) Ingestible Line with Innovative New Product
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that its lifestyle brand A88CBD(TM) will introduce new powder packs in four…
-
MissionIRNewsBreaks – Creatd Inc. (NASDAQ: CRTD) to Discuss Q3 Financials, Business Update During Webcast
Creatd (NASDAQ: CRTD), the parent company of Vocal, a proprietary technology platform for creators of all types, will hold a Nov. 17 webcast. During the webcast, company officials will discuss Creatd’s third-quarter 2020 financial numbers…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Expands Scientific Advisory Board with Strategic Appointment
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the addition of George K. Gittes, MD to its Scientific Advisory Board (“SAB”). According…
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Enters LOI with Asymchem for MS1819 Development, Production
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced its entry into a binding letter of intent (“LOI”) with Asymchem, a leading global contract development and…
-
MissionIRNewsBreaks – Sustainable Green Team Ltd. (SGTM) Releases Financial Report; Notes More Than $5.9M in Revenue for Q3
Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, has released its financial information, reporting another profitable quarter. A highlight of the report indicates that the…
-
Knightscope Creates AI-equipped Sentinels to Keep America’s Industries and Institutions Safe
Security robot developer Knightscope has created autonomous sentry models that patrol properties and collect data to maintain a heightened level of public safety The company currently markets a K1 stationary machine, K3 indoor machine and…
-
SRAX Inc. (NASDAQ: SRAX) Sells Remaining MD Stake For $8 Million, Focused on Growing SaaS Data Management Investor Platform
SRAX sells remaining MD ownership stake for $8 million MD sale allows SRAX to focus on rapid growth of Sequire platform Sequire unlocks big data investor insights for public companies Sequire revenue grew 29% year-over-year…
-
MissionIRNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) to Release Q3 2020 Financial Results, Host Conference Call
iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that it will report its unaudited third quarter 2020 financial results before the U.S. market opens…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Q2 2021 Financial Results
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today released its unaudited condensed interim consolidated financial statements and management’s discussion and analysis (“MD&A”) for the three and six months ended…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Unveil Adaptive Design for Berubicin Phase 2 Clinical Trial in Nov. 12 Webinar
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced its plans to issue a video update…
-
Predictive Oncology (NASDAQ: POAI) Subsidiary’s HSC Technology Optimization Solution Offers Unparalleled Results, Benefits
POAI subsidiary Soluble Biotech’s optimization solution shaves time and cost off of traditional options offered by competition Results garnered from company’s HSC optimization are unparalleled in field Soluble Biotech lands first major contract, signifying major…
-
Acquisition Strategy Paying Off for Sustainable Green Team, Ltd. (SGTM) Through Increased Profits, International Expansion
National Storm Recovery Inc. acquired Mulch Manufacturing Inc. several months ago to create SGTM SGTM diverts storm waste from landfills to create attractive next-generation products that benefit the environment Mulch Manufacturing recently secured many new…
-
MissionIRNewsBreaks – CYBIN Inc. Completes Reverse Takeover Transaction
CYBIN (formerly Clarmin Explorations Inc.), a life sciences company initially focused on psychedelic pharmaceutical therapies, on Thursday announced it has completed its previously disclosed reverse takeover of Clarmin Explorations Inc. per the terms of an…
-
Knightscope, Inc. Is ‘One to Watch’
Knightscope is a leader in the development of autonomous security capabilities and is on target to disrupt the $500 billion security industry The company is presently in the process of raising up to $25 million…
-
VistaGen Therapeutics’ (NASDAQ: VTGN) New Generation Phase 3 Drug Candidate for Social Anxiety Disorder Gains Importance Amid FDA Wariness of Benzodiazepines
VistaGen has three innovative CNS drug candidates which target a wide range of anxiety, depression and neurological disorders PH94B, the Company’s most advanced drug candidate, is entering Phase 3 development for acute, on-demand treatment of…
-
SRAX Inc.’s (NASDAQ: SRAX) Sequire Delivers Valuable Insights into Consumer Behaviors, Aids Publicly Traded Companies in Investor Growth
Since its launch in early 2019, Sequire has gained 1 million active investors, traders from 91 public companies New name — Sequire — represents platform’s main objective to acquire, secure investors for publicly traded companies…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Board Appointment of Dr. Khalid Islam
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with a high unmet medical need, today announced the appointment of Dr. Khalid Islam to its…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Its Alkaline88 Product Reaches No. 1 Spot at KeHE Winter Show
The Alkaline Water Company’s (NASDAQ: WTER) (CSE: WTER) flagship brand, Alkaline88(r), was the No. 1 item by cases sold at the recent KeHE Virtual Winter Show. The company produces premium bottled alkaline water, flavor-infused waters and…
-
MissionIRNewsBreaks– DarioHealth Corp. (NASDAQ: DRIO) to Report Q3 2020 Financial Results, Host Conference Call
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced that it will release financial results for its second quarter ended September 30, 2020, on Thursday, Nov. 12, 2020, as well as…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Reschedules Webcast for Nov. 4, 2020
Energy Fuels (NYSE American: UUUU) (TSX: EFR) on Tuesday announced that, due to technical issues, its conference call and webcast originally scheduled for Nov. 3, 2020, has been postponed to be held at 4:00 pm…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Research Report
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with high unmet medical need conditions, was featured in an institutional research report by Craig-Hallum Capital…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Eyes Expanded 4E Reserves, Cost Efficiencies at Waterberg
- MissionIRNewsBreaks – Why GlobalTech Corp. (GLTK) Is ‘One to Watch’
- Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ): Advancing Critical Minerals in Alaska’s Ambler Mining District
- Safe Pro Group Inc. (NASDAQ: SPAI) Partners with Drone Industry Leaders to Advance AI-Powered Threat Detection
- PowerBank Corporation’s (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) 5.7 MW North Main St Project Clears Interconnection Study, Moves Toward Permitting